Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse.

Chelu MG, Goonasekera SA, Durham WJ, Tang W, Lueck JD, Riehl J, Pessah IN, Zhang P, Bhattacharjee MB, Dirksen RT, Hamilton SL.

FASEB J. 2006 Feb;20(2):329-30. Epub 2005 Nov 11.

PMID:
16284304
2.

[Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle].

Monnier N, Lunardi J.

Ann Biol Clin (Paris). 2000 Mar-Apr;58(2):147-56. Review. French.

3.

Malignant hyperthermia: an inherited disorder of skeletal muscle Ca+ regulation.

Louis CF, Balog EM, Fruen BR.

Biosci Rep. 2001 Apr;21(2):155-68. Review.

PMID:
11725864
4.

Ryanodine receptor mutations in malignant hyperthermia and central core disease.

McCarthy TV, Quane KA, Lynch PJ.

Hum Mutat. 2000;15(5):410-7. Review.

PMID:
10790202
5.

Heat production during anesthetic-induced malignant hyperthermia.

Nelson TE.

Biosci Rep. 2001 Apr;21(2):169-79. Review.

PMID:
11725865
6.

Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulating proteins.

Nelson TE.

Curr Mol Med. 2002 Jun;2(4):347-69. Review.

PMID:
12108947
7.

Ryanodine receptors and their role in genetic diseases (review).

Leeb T, Brenig B.

Int J Mol Med. 1998 Sep;2(3):293-300. Review.

PMID:
9855701
8.
9.

Genetics of malignant hyperthermia.

Brandom BW.

ScientificWorldJournal. 2006 Dec 28;6:1722-30. Review.

10.

Defective Mg2+ regulation of RyR1 as a causal factor in malignant hyperthermia.

Steele DS, Duke AM.

Arch Biochem Biophys. 2007 Feb 1;458(1):57-64. Epub 2006 Mar 20. Review.

PMID:
16620769
11.

Malignant Hyperthermia Susceptibility.

Rosenberg H, Sambuughin N, Riazi S, Dirksen R.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A, Ledbetter N, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2003 Dec 19 [updated 2013 Jan 31].

12.

Malignant hyperthermia.

MacLennan DH, Phillips MS.

Science. 1992 May 8;256(5058):789-94. Review.

PMID:
1589759
13.

The genetic basis of malignant hyperthermia.

Moochhala SM, Tan WT, Lee TL.

Ann Acad Med Singapore. 1994 Jul;23(4):475-8. Review.

PMID:
7979121
14.

Core myopathies and risk of malignant hyperthermia.

Klingler W, Rueffert H, Lehmann-Horn F, Girard T, Hopkins PM.

Anesth Analg. 2009 Oct;109(4):1167-73. doi: 10.1213/ANE.0b013e3181b5ae2d. Review.

PMID:
19762745
15.
16.

The genetic basis of malignant hyperthermia.

MacLennan DH.

Trends Pharmacol Sci. 1992 Aug;13(8):330-4. Review.

PMID:
1329295
17.

DNA testing for malignant hyperthermia: the reality and the dream.

Stowell KM.

Anesth Analg. 2014 Feb;118(2):397-406. doi: 10.1213/ANE.0000000000000063. Review.

PMID:
24445638
18.

Calsequestrin-1: a new candidate gene for malignant hyperthermia and exertional/environmental heat stroke.

Protasi F, Paolini C, Dainese M.

J Physiol. 2009 Jul 1;587(Pt 13):3095-100. doi: 10.1113/jphysiol.2009.171967. Epub 2009 May 5. Review.

19.

Malignant hyperthermia: a pharmacogenetic disorder.

Stowell KM.

Pharmacogenomics. 2008 Nov;9(11):1657-72. doi: 10.2217/14622416.9.11.1657. Review.

PMID:
19018722
20.

Malignant hyperthermia: clinical and molecular aspects.

Correia AC, Silva PC, da Silva BA.

Rev Bras Anestesiol. 2012 Nov-Dec;62(6):820-37. doi: 10.1016/S0034-7094(12)70182-4. Review.

Supplemental Content

Support Center